Skip to main content
Equibles

UBS Group AG

Position in COYA — Coya Therapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to COYA Full portfolio

Position in COYA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$193,563
+$41,622 QoQ
Shares Held
33,088
-14.2% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 54 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in COYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. COYA ranks #338 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in COYA

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $193,563 33,088
2026-03-31 $151,941 38,564
2025-12-31 $203,202 35,035
2025-09-30 $75,798 13,298
2025-06-30 $86,979 15,127
2025-03-31 $220,555 34,089
2024-12-31 $246,538 43,026
2024-06-30 $64,817 10,696
2024-03-31 $5,952 600
2023-12-31 $18,369 2,479
2023-06-30 $108,269 26,602
2023-03-31 $11,310 2,846
2022-12-31 $5,756 1,215